United States · FDA National Drug Code directory
Citalopram
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-007_5642ea11-17b4-431a-a896-2cb336929100
- Product NDC
- 65862-007
- Form
- TABLET, FILM COATED
- Composition / generic term
- Citalopram Hydrobromide
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20041028
- Source listing expiry
- 20261231
Source-listed ingredients
- CITALOPRAM HYDROBROMIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (65862-007-01) · 65862-007-01
- 500 TABLET, FILM COATED in 1 BOTTLE (65862-007-05) · 65862-007-05
- 10 BLISTER PACK in 1 CARTON (65862-007-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 65862-007-10
- 30 TABLET, FILM COATED in 1 BOTTLE (65862-007-30) · 65862-007-30
- 30 TABLET, FILM COATED in 1 BLISTER PACK (65862-007-32) · 65862-007-32
- 60 TABLET, FILM COATED in 1 BOTTLE (65862-007-60) · 65862-007-60
- 90 TABLET, FILM COATED in 1 BOTTLE (65862-007-90) · 65862-007-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →